/INSP
INSP Stock - Inspire Medical Systems, Inc.
Healthcare|Medical - DevicesNYSE
$96.54+1.33%
+$1.27 (+1.33%) • Dec 19
68
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.20
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.92
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+39.7%upside
Target: $134.87
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for INSP
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$95.57 – $97.51
TARGET (TP)$134.83
STOP LOSS$88.82
RISK/REWARD1:5.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.70
52W High$216.01
52W Low$70.77
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $802.80M | $624.80M | $407.86M | $233.39M | $115.38M |
| Gross Profit | $679.82M | $528.22M | $341.74M | $200.12M | $97.76M |
| Gross Margin | 84.7% | 84.5% | 83.8% | 85.7% | 84.7% |
| Operating Income | $36.08M | $-40,271,000 | $-47,592,000 | $-39,850,000 | $-56,208,000 |
| Net Income | $53.51M | $-21,153,000 | $-44,881,000 | $-42,042,000 | $-57,203,000 |
| Net Margin | 6.7% | -3.4% | -11.0% | -18.0% | -49.6% |
| EPS | $1.80 | $-0.72 | $-1.60 | $-1.54 | $-2.19 |
Company Overview
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
13
62%
Hold / Neutral
8
38%
Sell / Underperform
0%
Analyst Consensus🟡 Mixed
13 Bullish8 Neutral/Bearish
Price Targets
$215
Average Target
↑ 123.1% Upside
Now
$85
Low
$215
Average
$371
High
Based on 25 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 8th 2025 | Oppenheimer | Upgrade | Outperform | $175 |
| December 2nd 2025 | Morgan Stanley | Downgrade | Equal Weight | $130 |
| November 26th 2025 | Truist | Upgrade | Buy | $165 |
| November 25th 2025 | Wolfe Research | Upgrade | Outperform | $180 |
| November 24th 2025 | Stifel | Upgrade | Buy | - |
| November 4th 2025 | Wells Fargo | Upgrade | Overweight | $90 |
| October 24th 2025 | Jefferies | Downgrade | Hold | $85 |
| September 22nd 2025 | UBS | Downgrade | Neutral | $89 |
| September 2nd 2025 | Evercore ISI | Initiation | Outperform | $150 |
| August 5th 2025 | Truist | Downgrade | Hold | $125 |
| August 5th 2025 | KeyBanc Capital Markets | Downgrade | Sector Weight | - |
| August 5th 2025 | JP Morgan | Downgrade | Neutral | $110 |
| November 20th 2024 | BofA Securities | Upgrade | Buy | $255← $220 |
| May 8th 2024 | BofA Securities | Downgrade | Neutral | $225← $265 |
| April 19th 2024 | RBC Capital Mkts | Initiation | Outperform | $285 |
Earnings History & Surprises
INSPBeat Rate
100%
Last 18 quarters
Avg Surprise
+151.4%
EPS vs Estimate
Beats / Misses
18/0
Last 12 quarters
Latest EPS
$0.38
Q4 2025
EPS Surprise History
Q1 24
+644.4%
$0.49vs$-0.09
Q2 24
+46.0%
$-0.34vs$-0.63
Q3 24
+328.6%
$0.32vs$-0.14
Q4 24
+650.0%
$0.60vs$0.08
Q1 25
+55.4%
$1.15vs$0.74
Q2 25
+143.5%
$0.10vs$-0.23
Q3 25
+104.5%
$0.45vs$0.22
Q4 25
+353.3%
$0.38vs$-0.15
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 4, 2026 | — | — | — | — |
Q1 2026 | Feb 9, 2026 | $0.70 | — | — | — |
Q4 2025 | Nov 3, 2025 | $-0.15 | $0.38 | +353.3% | ✓ BEAT |
Q3 2025 | Aug 4, 2025 | $0.22 | $0.45 | +104.5% | ✓ BEAT |
Q2 2025 | May 5, 2025 | $-0.23 | $0.10 | +143.5% | ✓ BEAT |
Q1 2025 | Feb 10, 2025 | $0.74 | $1.15 | +55.4% | ✓ BEAT |
Q4 2024 | Nov 4, 2024 | $0.08 | $0.60 | +650.0% | ✓ BEAT |
Q3 2024 | Aug 6, 2024 | $-0.14 | $0.32 | +328.6% | ✓ BEAT |
Q2 2024 | May 7, 2024 | $-0.63 | $-0.34 | +46.0% | ✓ BEAT |
Q1 2024 | Feb 6, 2024 | $-0.09 | $0.49 | +644.4% | ✓ BEAT |
Q4 2023 | Nov 7, 2023 | $-0.53 | $-0.29 | +45.3% | ✓ BEAT |
Q3 2023 | Aug 1, 2023 | $-0.51 | $-0.41 | +19.6% | ✓ BEAT |
Q2 2023 | May 2, 2023 | $-0.70 | $-0.53 | +24.3% | ✓ BEAT |
Q1 2023 | Feb 7, 2023 | $-0.57 | $0.10 | +117.5% | ✓ BEAT |
Q4 2022 | Nov 1, 2022 | $-0.75 | $-0.60 | +20.0% | ✓ BEAT |
Q3 2022 | Aug 2, 2022 | $-0.59 | $-0.53 | +10.2% | ✓ BEAT |
Q2 2022 | May 3, 2022 | $-0.78 | $-0.61 | +21.8% | ✓ BEAT |
Q1 2022 | Feb 8, 2022 | $-0.47 | $-0.09 | +80.9% | ✓ BEAT |
Q4 2021 | Nov 2, 2021 | $-0.61 | $-0.38 | +37.7% | ✓ BEAT |
Q3 2021 | Aug 3, 2021 | $-0.61 | $-0.48 | +21.3% | ✓ BEAT |
Latest News
Inspire Medical slides after Medicare reimbursement policy change
📉 NegativeSeeking Alpha•Dec 18, 2025, 04:45 PM
RBC Capital Maintains Outperform on Inspire Medical Systems, Raises Price Target to $175
📈 PositiveBenzinga•Dec 17, 2025, 01:16 PM
Mizuho Maintains Outperform on Inspire Medical Systems, Raises Price Target to $130
📈 PositiveBenzinga•Dec 17, 2025, 01:04 PM
JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $118
➖ NeutralBenzinga•Dec 16, 2025, 03:59 PM
Piper Sandler Maintains Overweight on Inspire Medical Systems, Raises Price Target to $165
📈 PositiveBenzinga•Dec 8, 2025, 02:11 PM
Oppenheimer Upgrades Inspire Medical Systems to Outperform, Announces $175 Price Target
📈 PositiveBenzinga•Dec 8, 2025, 01:50 PM
Baird Maintains Outperform on Inspire Medical Systems, Raises Price Target to $180
📈 PositiveBenzinga•Dec 4, 2025, 01:45 PM
Morgan Stanley Downgrades Inspire Medical Systems to Equal-Weight, Raises Price Target to $130
➖ NeutralBenzinga•Dec 2, 2025, 05:43 PM
Truist Securities Upgrades Inspire Medical Systems to Buy, Raises Price Target to $165
📈 PositiveBenzinga•Nov 26, 2025, 01:10 PM
Inspire Medical Systems shares are trading higher after Wolfe Research upgraded the stock from Peer Perform to Outperform and set a $180 price target.
📈 PositiveBenzinga•Nov 25, 2025, 04:13 PM•Also:
Wolfe Research Upgrades Inspire Medical Systems to Outperform, Announces $180 Price Target
📈 PositiveBenzinga•Nov 25, 2025, 03:58 PM•Also:
Shares of Inspire Medical Systems are trading higher after Stifel upgraded the stock from Hold to Buy and raised the price target from $100 to $110.
📈 PositiveBenzinga•Nov 24, 2025, 05:38 PM•Also:
Stifel Upgrades Inspire Medical Systems to Buy, Raises Price Target to $110
📈 PositiveBenzinga•Nov 24, 2025, 05:33 PM•Also:
Inspire jumps on major change to Medicare reimbursement
📈 PositiveSeeking Alpha•Nov 24, 2025, 03:45 PM
Piper Sandler Reiterates Overweight on Inspire Medical Systems, Lowers Price Target to $135
➖ NeutralBenzinga•Nov 4, 2025, 04:43 PM
RBC Capital Maintains Outperform on Inspire Medical Systems, Lowers Price Target to $125
📈 PositiveBenzinga•Nov 4, 2025, 04:29 PM
Truist Securities Reiterates Hold on Inspire Medical Systems, Lowers Price Target to $84
➖ NeutralBenzinga•Nov 4, 2025, 03:45 PM
JP Morgan Maintains Neutral on Inspire Medical Systems, Lowers Price Target to $82
📉 NegativeBenzinga•Nov 4, 2025, 03:30 PM
Inspire Medical Systems shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 GAAP EPS results above estimates.
📈 PositiveBenzinga•Nov 4, 2025, 01:48 PM
Wells Fargo Upgrades Inspire Medical Systems to Overweight, Lowers Price Target to $90
➖ NeutralBenzinga•Nov 4, 2025, 12:38 PM
Frequently Asked Questions about INSP
What is INSP's current stock price?
Inspire Medical Systems, Inc. (INSP) is currently trading at $96.54 per share. The stock has moved +1.33% today.
What is the analyst price target for INSP?
The average analyst price target for INSP is $134.83, based on 1 analyst.
What sector is Inspire Medical Systems, Inc. in?
Inspire Medical Systems, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NYSE exchange.
What is INSP's market cap?
Inspire Medical Systems, Inc. has a market capitalization of $2.86 billion, making it a mid-cap company.
Does INSP pay dividends?
No, Inspire Medical Systems, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADUS
Addus HomeCare Corporation
$112.82
Mkt Cap: $2.1B
AORT
Artivion, Inc.
$46.55
Mkt Cap: $2.2B
ARDT
Ardent Health Partners, LLC
$8.81
Mkt Cap: $1.3B
BKD
Brookdale Senior Living Inc.
$10.79
Mkt Cap: $2.6B
ETNB
89bio, Inc.
$14.84
Mkt Cap: $2.2B
ITGR
Integer Holdings Corporation
$78.58
Mkt Cap: $2.8B
LMAT
LeMaitre Vascular, Inc.
$84.96
Mkt Cap: $1.9B
PINC
Premier, Inc.
$28.26
Mkt Cap: $2.3B
PRCT
PROCEPT BioRobotics Corporation
$32.06
Mkt Cap: $1.8B
RCUS
Arcus Biosciences, Inc.
$21.98
Mkt Cap: $2.4B
Explore stocks similar to INSP for comparison